To the central content area
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

4174 OBI
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Michael N. Chang Michael N. Chang Michael N. Chang (02)2655-8799 19F, No.3, Yuan Qu Street , Nangang Software ParkTaipei City 11503, Taiwan R.O.C 2015/03/23
Industry Main Business
Biotechnology and Medical Care OBI Pharma, Inc. (OBI) is a biotech company to develop novel therapeutic agents for diseases that are currently lacking treatment options. The initial therapeutic focus will be cancer and osteoarthritis. OBI is positioned as a new product development company strives to improve health and quality of life through innovative and cost effective medicine. OBI will initiate clinical study, set up internal R & D programs, corporate operation, and establishing collaboration with Academia Sinica, Taipei, Taiwan.
 
Market Information ( 2022/09/23 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
826.821 80.60  76.50  77.30  -1.70  732 0.36 3,387 150
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2022/09/23)
TPEx measures
adopted
(2022/09/23)
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.